Total Payments
$2,452
2024 Payments
$914.27
Companies
36
Transactions
138
Medicare Patients
140
Medicare Billing
$9,057
Payment Breakdown by Category
Food & Beverage$2,452 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,452 | 138 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $311.11 | 20 | $0 (2024) |
| Amgen Inc. | $295.14 | 15 | $0 (2024) |
| ABBVIE INC. | $283.71 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $216.32 | 8 | $0 (2024) |
| Lilly USA, LLC | $191.94 | 13 | $0 (2024) |
| Scilex Pharmaceuticals Inc. | $134.25 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $78.73 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $69.73 | 4 | $0 (2024) |
| Mylan Specialty L.P. | $65.53 | 4 | $0 (2023) |
| Horizon Therapeutics plc | $64.70 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $914.27 | 46 | Amgen Inc. ($202.32) |
| 2023 | $554.88 | 31 | ABBVIE INC. ($83.34) |
| 2022 | $515.32 | 33 | ABBVIE INC. ($142.17) |
| 2021 | $467.51 | 28 | Boehringer Ingelheim Pharmaceuticals, Inc. ($77.99) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Bone Health | ||||||
| 10/25/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $45.49 | General |
| 09/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/23/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $48.16 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 08/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.56 | General |
| Category: DIABETES | ||||||
| 08/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/08/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Neurology | ||||||
| 08/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Bone Health | ||||||
| 07/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Durable Pump | ||||||
| 06/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: PSYCHIATRY | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Gastroenterology | ||||||
| 05/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 27 | 29 | $6,322 | $1,100 |
| 2020 | 4 | 113 | 129 | $58,870 | $7,957 |
Total Patients
140
Total Services
158
Medicare Billing
$9,057
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 29 | $6,322 | $1,100 | 17.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 56 | 71 | $15,478 | $3,242 | 20.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 29 | $9,367 | $2,064 | 22.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $9,000 | $1,892 | 21.0% |
| 36821 | Relocation of arm vein with connection to arm artery, open procedure | Facility | 2020 | 11 | 11 | $25,025 | $759.25 | 3.0% |
About Joel Wise, PA
Joel Wise, PA is a Surgical healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2018. The National Provider Identifier (NPI) number assigned to this provider is 1548752744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joel Wise, PA has received a total of $2,452 in payments from pharmaceutical and medical device companies, with $914.27 received in 2024. These payments were reported across 138 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($2,452).
As a Medicare-enrolled provider, Wise has provided services to 140 Medicare beneficiaries, totaling 158 services with total Medicare billing of $9,057. Data is available for 2 years (2020–2021), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgical
- Location Fort Worth, TX
- Active Since 06/04/2018
- Last Updated 08/02/2018
- Taxonomy Code 363AS0400X
- Entity Type Individual
- NPI Number 1548752744
Products in Payments
- REXULTI (Drug) $283.82
- KRYSTEXXA (Biological) $240.05
- JARDIANCE (Drug) $229.34
- VRAYLAR (Drug) $174.91
- TRULICITY (Drug) $103.89
- Otezla (Drug) $92.82
- ZTLido (Drug) $88.06
- QULIPTA (Drug) $81.90
- LEQVIO (Drug) $69.73
- MOUNJARO (Drug) $60.09
- Yupelri (Drug) $49.21
- INNOVAMATRIX AC (Device) $48.16
- TRELEGY ELLIPTA (Drug) $47.92
- XIFAXAN (Drug) $39.87
- Flexitouch Plus (Device) $39.57
- Edarbyclor (Drug) $36.07
- Vascepa (Drug) $35.38
- Ozempic (Drug) $32.22
- BEXSERO (Biological) $30.81
- BELSOMRA (Drug) $29.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgical Doctors in Fort Worth
Mr. Shakeel Sharif, P.a, P.A
Surgical — Payments: $8,732
Surgical $8,732
Paulina Purnama, Pa-C, PA-C
Surgical — Payments: $4,199
Surgical $4,199
Russell Smith, Pa, PA
Surgical — Payments: $3,547
Surgical $3,547
Laine Markham, Pa-C, PA-C
Surgical — Payments: $1,878
Surgical $1,878
Ashley Hines, Pa-C, PA-C
Surgical — Payments: $1,857
Surgical $1,857
Renata Castelo
Surgical — Payments: $1,807
Surgical $1,807